Dr. Ambati – AUPO 2018 Awardees Selected

October 2, 2018 by Elizabeth   |   Leave a Comment

Jayakrishna Ambati, MD

Jayakrishna Ambati, MD – RPB David F. Weeks Award for Outstanding AMD Research
Dr. Ambati is Professor and Vice Chair for Research, Ophthalmology, at the University of Virginia in Charlottesville, Virginia. The Weeks Award, which carries the name of David F. Weeks, former President and Chairman of Research to Prevent Blindness, in honor of his contributions to the field of vision research, recognizes and celebrates Dr. Ambati’s excellence in research focused on age-related macular degeneration.  Dr. Ambati will be presented with his award and will deliver a presentation in January at the 2019 AUPO Annual Meeting.

Research to Prevent Blindness and Association of University Professors of Ophthalmology Announce 2018 Recipient of RPB David F. Weeks Award for Outstanding AMD Research

Jayakrishna Ambati, MD, is recognized for pioneering contributions to the field of age-related macular degeneration research

 Jayakrishna Ambati, MD, has been selected as the 2018 RPB David F. Weeks Award for Outstanding AMD Research (Weeks Award). The Weeks Award, funded through the generosity of Research to Prevent Blindness (RPB), an anonymous donor, and the Association of University Professors of Ophthalmology (AUPO), annually recognizes and celebrates an excellent researcher focused on age-related macular degeneration (AMD). The award carries the name of David F. Weeks, former President and Chairman of RPB, in honor of his contributions to the field of vision research. Dr. Ambati will receive his award and deliver a presentation on January 25, 2019 at the AUPO Annual Meeting in Fort Lauderdale, Florida.

Dr. Ambati is Vice Chair for Research in the Department of Ophthalmology at the University of Virginia and founder of the Center for Advanced Vision Science (CAVS). Dr. Ambati is being honored for his research on the molecular bases of macular degeneration. He shared, “As an ophthalmology resident, I was struck by our inability to alter the inexorable course of blindness faced by the many AMD patients I saw every day.  Therefore, I resolved to dedicate my energies to tackling this problem, which affected millions of people around the globe.”

“Throughout David F. Weeks’ distinguished 50-year career at Research to Prevent Blindness, he not only shaped the work of the organization, but also helped to develop the field of vision research. I personally am indebted to him because in my work at RPB, I ‘stand on his shoulders’,” said Brian F. Hofland, PhD, President of Research to Prevent Blindness.  “Mr. Weeks has AMD himself.  Therefore, I am so pleased that this year’s award winner is someone who significantly has impacted the field of   vision research through his excellent work on AMD. Together with RPB’s Board of Trustees, I extend sincere congratulations to Dr. Ambati on this honor.”

“Dr. Ambati’s research has illuminated previously unknown links between molecular triggers of inflammation and macular degeneration,” said AUPO President Russell N. Van Gelder, MD, PhD.  “Dr. Ambati has contributed substantially to the understanding of AMD at the level of single molecules and has brought the attention of the broader scientific community to this unique disease and its causes in a series of highly impactful publications in leading scientific journals. His work has led directly to promising treatments for slowing dry macular degeneration.”

For more information on the RPB David F. Weeks Award for Outstanding AMD Research, visit the AUPO website.

https://aupo.org/news/2018-07/aupo-2018-awardees-selected

https://www.rpbusa.org/rpb/news-and-publications/news/latest/rpb-aupo-dfw-award-for-amd-research/

A Recognition of Great Work on Macular Degeneration

Dr. Jayakrishna Ambati receives the prestigious the 2018 RPB David F. Weeks Award for Outstanding AMD Research

Filed Under: Macular Degeneration, Research, Retina, Vision

Tags: , , , , , ,

 

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *